| Identification | Back Directory | [Name]
ethyl 2-[({[(2-hydroxyethyl)aMino]carbonyl}oxy)Methyl]-5,7-diMethyl-3-{2-[(MethylaMino)sulfonyl]phenyl}-4-oxo-3,4-dihydroquinazoline-6-carboxylate | [CAS]
581106-09-4 | [Synonyms]
SAD448
SAD-448
SAD 448
SAD 448,SAD448
ethyl 2-[({[(2-hydroxyethyl)aMino]carbonyl}oxy)Methyl]-5,7-diMethyl-3-{2-[(MethylaMino)sulfonyl]phenyl}-4-oxo-3,4-dihydroquinazoline-6-carboxylate | [Molecular Formula]
C24H28N4O8S | [MDL Number]
MFCD26395645 | [MOL File]
581106-09-4.mol | [Molecular Weight]
532.566 |
| Hazard Information | Back Directory | [Uses]
SAD448 is a CB1 and CB2 receptor agonist. SAD448 can lower intraocular pressure (IOP)[1]. | [References]
[1] Pryce G, et al. Control of spasticity in a multiple sclerosis model using central nervous system-excluded CB1 cannabinoid receptor agonists. FASEB J. 2014 Jan;28(1):117-30. DOI:10.1096/fj.13-239442 |
|
|